News about Drug Discovery & Development

Cyrano Therapeutics Completes Enrollment in Phase 2 FLAVOR Trial of CYR-064 for Post-Viral Smell Loss

Cyrano Therapeutics has completed enrollment in its Phase 2 FLAVOR trial evaluating CYR-064, a novel soft-mist nasal spray for the treatment of post-viral smell loss, with results expected in late 2025.

Drug Discovery & Development | 10/04/2025 | By Manvi

ProFuse Launches Drug Discovery Platform for Prevention of Muscle Loss

ProFuse's technology is based on developing methods to generate highly mature muscle tissues that accurately reflect the structure and function of natural human muscle.

Drug Discovery & Development | 05/04/2025 | By Aishwarya

IRBM Expands Functional Genomics Platform to Boost Early Drug Discovery

The platform integrates CRISPR-based methodologies, screening capabilities, cell engineering, and advanced molecular and cellular analysis to drive both target discovery and validation.

Drug Discovery & Development | 05/04/2025 | By Aishwarya

Astellas and Japanese Foundation for Cancer Research to Accelerate Clinical Oncology Research

Through this collaboration, Astellas is committed to strengthening translational science and clinical research in order to deliver innovative new medicines.

Drug Discovery & Development | 04/04/2025 | By Aishwarya |  105

Redwire Secures NASA Contract to Expand Pharmaceutical Drug Development in Space

With 28 units flown and processed to date, PIL-BOX provides pharmaceutical researchers with novel and flexible services to leverage the microgravity environment to grow small-batch crystals of protein-based pharmaceuticals and other key pharmaceutically relevant molecules.

Drug Discovery & Development | 28/03/2025 | By Aishwarya

Merck Signs Exclusive License Deal for HRS-5346 with Hengrui Pharma

Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.

Drug Discovery & Development | 26/03/2025 | By Aishwarya |  138

ENTOD Pharma Unveils Advanced Veterinary Ear Drops to Combat Ear Mites in Pets

This launch marks ENTOD Pharmaceuticals' continued commitment to innovating in veterinary eye and ear care solutions under its specialised FUR by ENTOD (Veterinary) division.

Drug Discovery & Development | 26/03/2025 | By Aishwarya

TUL Signs Exclusive License Deal with Novo Nordisk for UBT251

Under the license agreement, Novo Nordisk will obtain exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture, and commercialize UBT251.

Drug Discovery & Development | 25/03/2025 | By Aishwarya

Everest Medicines Receives FDA Clearance of IND Application for EVM14

EVM14 is an off-the-shelf mRNA cancer vaccine targeting multiple TAAs and is designed to treat various cancers, including non-small cell lung cancer and head and neck cancer.

Drug Discovery & Development | 24/03/2025 | By Aishwarya

Actinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering Cancer Center

Actinium Pharmaceuticals has entered a research collaboration with Memorial Sloan Kettering Cancer Center to expand Actimab-A’s mutation-agnostic mechanism in AML through targeted therapy combinations and patient-derived models.

Drug Discovery & Development | 20/03/2025 | By Aishwarya